STING agonists drive intrinsic type I interferon responses in monocytes for optimal anti-tumor immunity

被引：0
|
作者：
Yu, Tianning
Girard, Melanie
Watts, Tania H.
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2023年 / 11卷 / 12期
关键词：
D O I：
10.1158/2326-6074.TUMIMM23-A012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A012
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Adenosine inhibits STING driven anti-tumor immunity in pancreatic cancer
    Premji, Alykhan
    Link, Jason
    Yamao, Takanobu
    Rashid, Khalid
    Abt, Evan
    Labora, Amanda
    Chan, Charlotte
    Le, Thuc
    Wainberg, Zev
    Radu, Caius
    Donahue, Timothy
    CANCER RESEARCH, 2024, 84 (02)
  • [12] Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
    Daniel S. Leventhal
    Anna Sokolovska
    Ning Li
    Christopher Plescia
    Starsha A. Kolodziej
    Carey W. Gallant
    Rudy Christmas
    Jian-Rong Gao
    Michael J. James
    Andres Abin-Fuentes
    Munira Momin
    Christopher Bergeron
    Adam Fisher
    Paul F. Miller
    Kip A. West
    Jose M. Lora
    Nature Communications, 11
  • [13] Telomere Stress Potentiates STING-Dependent Anti-tumor Immunity
    Mender, Ilgen
    Zhang, Anli
    Ren, Zhenhua
    Han, Chuanhui
    Deng, Yafang
    Siteni, Silvia
    Li, Huiyu
    Zhu, Jiankun
    Vemula, Aishwarya
    Shay, Jerry W.
    Fu, Yang-Xin
    CANCER CELL, 2020, 38 (03) : 400 - +
  • [14] Optogenetic Engineering of STING Signaling to Remotely Control anti-Tumor Immunity
    Liu, Siyao
    PHYSIOLOGY, 2024, 39
  • [15] STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer
    Vonderhaar, Emily P.
    Barnekow, Nicholas S.
    McAllister, Donna
    McOlash, Laura
    Abu Eid, Mahmoud
    Riese, Matthew J.
    Tarakanova, Vera L.
    Johnson, Bryon D.
    Dwinell, Michael B.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2021, 12 (01): : 41 - 58
  • [16] Suppressing type I interferon enhances both autoimmunity and anti-tumor immunotherapy
    Riding, Rebecca L.
    Fukuda, Keitaro
    Richmond, Jillian M.
    Harris, John E.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [17] Intrinsic and acquired resistance to RIG-I induced anti-tumor responses.
    Anand, Sudarshan
    Fraile-Bethencourt, Eugenia
    Khou, Sokchea
    CLINICAL CANCER RESEARCH, 2021, 27 (08)
  • [18] Intrinsic and acquired resistance to RIG-I induced anti-tumor responses.
    Fraile-Bethencourt, Eugenia
    Khou, Sokchea
    Anand, Sudarshan
    CANCER RESEARCH, 2021, 81 (13)
  • [19] Novel small-molecule human STING agonists generate robust Type I interferon responses in tumors
    Banerjee, Monali
    Middya, Sandip
    Basu, Sourav
    Shrivastava, Ritesh
    Ghosh, Rajib
    Yadav, Dharmendra
    Soram, Thanilsana
    Raina, Ritika
    Pryde, David C.
    Puniya, Kavita
    Pandit, Navin
    Mansuri, Rubeenaparveen R.
    Kadam, Vijay
    Debnath, Sabyasachi
    Goon, Sunny
    Singh, Anuj
    Middya, Anindita
    Rawat, Nidhi
    Surya, Arjun
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [20] Telomere stress potentiates host STING-dependent anti-tumor immunity
    Zhang, Anli
    Mender, Ilgen
    Ren, Zhenhua
    Han, Chuanhui
    Deng, Yafang
    Siteni, Silvia
    Li, Huiyu
    Shay, Jerry W.
    Fu, Yang-Xin
    CANCER RESEARCH, 2020, 80 (16)
12345